Coloplast veteran appointed CEO of Neuspera Medical

The US-based medtech company has found its new chief executive in Steffen Hovard, who spent more than a decade at Danish medtech company Coloplast.

Steffen Hovard (right) next to former Ambu CEO Lars Marcher

Neuspera Medical, a US-based developer of medical devices meant to be less invasive for patients, has tapped Steffen Hovard for the chief executive spot, according to a company announcement.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs